Delivery Order SPE2DB22D2006-SPE2DB25FW2VM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,911.94 to AmerisourceBergen Drug Corp for 100 tablets of Onfivamide 10 mg, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,444.80 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the vendor's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2VMDelivery Order
The Defense Logistics Agency awarded a $7,436.43 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfiant 10 mg, with delivery expected by July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The IDC vehicle enables flexible sourcing of brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic areas to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 7/25/25 |